Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-017104

CHIEF FINANCIAL OFFICER acquired 298,837 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shah Amit B. · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-07-08 Grant or award : show line 1 in the form +298,837 358,837 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-07-08 Grant or award : show line 2 in the form Stock Options +698,256 698,256 D
Loading xslF345X03/ownership.xml…